Venus Remedies Limited Actinomycin Export Data — India (DGFT 2022–2026)

Name: Venus Remedies Limited Actinomycin Export Records India — #7 Exporter, 5 Shipments, $35.6K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Actinomycin

India Pharmaceutical Trade Intelligence

$2.9M184 Suppliers97 CountriesHS 30049046

ExportsIndia → UNITED STATES73.5%India → BRAZIL8.4%

ImportsUNITED STATES → India$114

#1 Supplier: EUGIA PHARMA #1 Buyer: EUGIA US

Venus Remedies Limited — Actinomycin Exporter #7 | $35.6K Trade Value | TransData Nexus | TransData Nexus

Venus Remedies Limited — Actinomycin Exporter Profile

Indian Pharmaceutical Exporter · #7 for Actinomycin · $35.6K export value · DGFT Verified

Venus Remedies Limited is the #7 Indian exporter of Actinomycin with $35.6K in export value and 5 verified shipments. Venus Remedies Limited holds a 1.2% market share in Actinomycin exports across 4 countries. The company exports 29 pharmaceutical products worth $86.4M across 6 therapeutic categories.

Venus Remedies Limited — Actinomycin Export Profile: Buyers & Destinations

Venus Remedies Limited Actinomycin export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Actinomycin?

Country	Value	Shipments	Share
UNITED STATES	$900.0K	18	63.1%
BRAZIL	$245.8K	324	17.2%
UGANDA	$37.6K	22	2.6%
ETHIOPIA	$36.0K	11	2.5%

Who Are the Top Buyers of Actinomycin from India?

Buyer	Country	Value	Orders
AUROLOGISTIC LLC	UNITED STATES	$200.0K	4
EUGIA US LLC	UNITED STATES	$150.0K	3
EUGIA US LLC,	UNITED STATES	$100.0K	2
ONCOPHARM SPECIALITY PHARMACY	UGANDA	$33.2K	3
ETHIOPIAN PHARMACEUTICALS	ETHIOPIA	$25.4K	2
TO THE	BRAZIL	$25.0K	33
EXP CODE	BRAZIL	$10.2K	11
TO THE MANAGER-	BRAZIL	$8.1K	2
TO THE,	BRAZIL	$7.9K	15

India's Actinomycin is purchased by 351 buyers worldwide. The top buyer is AUROLOGISTIC LLC (UNITED STATES), followed by EUGIA US LLC and EUGIA US LLC,.

How Does Venus Remedies Limited Compare to Nearest Actinomycin Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
5	GNH INDIA PHARMACEUTICALS LIMITED	$53.4K	56	4	$953
6	VAMA LIFECARE PRIVATE LIMITED	$44.7K	59	5	$757
7	VENUS REMEDIES LIMITED ★	$35.6K	5	4	$7.1K
8	ZUVIUS LIFESCIENCES PRIVATE LIMITED	$34.5K	8	4	$4.3K
9	FLORENCIA HEALTHCARE	$22.1K	3	3	$7.4K

Venus Remedies Limited ranks #7 among 184 Indian Actinomycin exporters. Average shipment value of $7.1K compared to the market average of $4.8K. The closest competitors by value are GNH INDIA PHARMACEUTICALS LIMITED and VAMA LIFECARE PRIVATE LIMITED.

Which Indian Ports Ship Actinomycin Exports?

Port	Shipments	% Share
SAHAR AIR	304	32.6%
SAHAR AIR CARGO ACC (INBOM4)	184	19.7%
DELHI AIR	108	11.6%
Bombay Air	82	8.8%
DELHI AIR CARGO ACC (INDEL4)	62	6.6%
AHEMDABAD AIR	21	2.3%
Bombay Air Cargo	20	2.1%
Delhi Air	18	1.9%

Geopolitical & Trade Policy Impact on Venus Remedies Limited's Actinomycin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Venus Remedies. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing transit times and costs for exports to Europe and the Americas. Such disruptions necessitate strategic adjustments in logistics and supply chain management to maintain timely deliveries and cost-effectiveness.

Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their presence in the U.S. market. India now supplies 40% of the U.S.'s generic drug needs, reflecting a growing reliance on Indian manufacturers. (ibef.org) Venus Remedies' recent QIDP designation from the U.S. FDA for VRP-034 positions the company favorably to leverage this opportunity, potentially enhancing its market share in the U.S.

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains critical. Venus Remedies' renewal of the EU-GMP certification indicates their proactive approach to meeting stringent EU regulations, thereby ensuring continued access to European markets. (business-standard.com)

Venus Remedies Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Venus Remedies has demonstrated a consistent commitment to quality, as evidenced by multiple GMP certifications. In addition to the EU-GMP renewal, the company secured GMP certification from Moldova's Ministry of Health in January 2025, covering their antibiotic-carbapenem manufacturing facility. (apnnews.com) Furthermore, the renewal of Ukrainian GMP certification in May 2025 for their Baddi facility underscores their adherence to global quality standards. (apnnews.com)

These certifications not only facilitate market access but also enhance the company's reputation as a reliable supplier of high-quality pharmaceuticals. In an industry where regulatory compliance is closely scrutinized, Venus Remedies' proactive measures position them favorably among global competitors.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Actinomycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Venus Remedies Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 97+ countries, 351+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Actinomycin

Actinomycin

Venus Remedies Limited — Actinomycin Exporter Profile

Venus Remedies Limited — Actinomycin Export Profile: Buyers & Destinations

Where Does India Export Actinomycin?

Who Are the Top Buyers of Actinomycin from India?

What Is India's Total Actinomycin Export Value and How Much Does Venus Remedies Limited Contribute?

What Is the Average Shipment Value for Venus Remedies Limited's Actinomycin Exports?

How Does Venus Remedies Limited Compare to Other Indian Actinomycin Exporters?

Regulatory Requirements: Exporting Actinomycin to Key Markets

United States — FDA

Brazil — ANVISA

How Does Venus Remedies Limited Compare to Nearest Actinomycin Exporters?

Which Indian Ports Ship Actinomycin Exports?

What Other Advanced Oncology Products Does Venus Remedies Limited Export?

Geopolitical & Trade Policy Impact on Venus Remedies Limited's Actinomycin Exports

Venus Remedies Limited — Regulatory Compliance & Quality Standards

About Venus Remedies Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Actinomycin Export Data from Venus Remedies Limited

Actinomycin Stats

Company Overview

Top Products by Venus Remedies Limited

Related Analysis

Need Detailed Export Data?

Data Source